BioSpace News Archive

Roivant Sciences (Nasdaq: ROIV) today announced the pricing of an upsized underwritten public offering of 26,666,666 of its common shares at a price to the public of $7.50 per share.

The Center for Global Health Innovation announced that Gary M. Reedy will be their new chairman.

Novocardia, a value-based cardiovascular disease care platform, and My Cardiologist, a trusted provider of cardiovascular services in South Florida for more than 60 years, are pleased to announce the launch of The Women’s Heart Health Program in South Florida.

ASPIVIX SA today announced that Carevix™, its novel Cervical Stabilizer, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

enGene, Inc., a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues enabled by its proprietary DDX platform, today announced that Alex Nichols, PhD, has joined the company as President and Chief Operating Officer.

CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2022.

StageZero Life Sciences, Ltd. (TSX: SZLS) (OTCQB: SZLSF) (“StageZero” or the “Company”), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announced today that its special meeting (the “Meeting”) originally scheduled for Tuesday February 28, will now be combined with the Annual General Meeting (“AGM”) in Q2 2023.

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2022.

Johnson & Johnson will participate in the Cowen 43rd Annual HealthCare Conference on Tuesday, March 7th, at the Boston Marriott Copley Place, Boston, MA.

Olema Pharmaceuticals, Inc. announced that the Company granted stock options to four new employees to purchase an aggregate of 97,200 shares of the Company’s common stock, effective as of February 1, 2023.